BACKGROUND: The benefit of probiotics in newborn children in relation to allergy and general morbidity later in life appears to be controversial. Allergic diseases represent an increasingly important health problem worldwide in recent years. This is evident in all age groups. The occurrence of allergic illnesses also continues to rise exponentially, and thus the use of preventive and prognostic methods, particularly in children with an inherently higher risk of allergy, is gaining increased importance. Since the advent of probiotics the effect of probiosis on immunity through alterations of composition and function of the human gut microbiome has been increasingly studied. The exact mechanisms have not yet been clearly defined. The Academy of Sciences of the Czech Republic (The Czech Academy of Sciences has suggested that the expression of TH1 and TH2 cytokines in umbilical blood is associated with an increased risk of allergies. The counter -balance of Th1 and Th2 affect Immunoglobulin E (IgE) production and maturation of the gastrointestinal tract epithelium. CASE PRESENTATION: We examined IgE levels in 3000 samples of umbilical blood taken from children born into families with a positive history of allergy in one or both parents from 2007 to 2017. At the age of ten days, those with high IgE were given Colinfant Newborn (a lyophilized non-pathogenic strain of Escherichia.coli) for one month, three times weekly. At 15 months and three years we investigated the levels of Immunoglobulins E,A and G, and the incidence of illness and allergy. The results revealed that allergy and high umbilical IgE is strongly linked with family history (p ≤ 0.001). We also detected differences in seasonality, especially with regards to pollen allergies. Eighty percent of children treated with Colinfant Newborn had significantly reduced IgE and morbidity at 13-15 months and 3 years, and furthermore without any clinical signs of allergy. Normalization of Immunoglobulins A and G was seen in 90% of treated subjects (p ≤ 0.001). These levels significantly correlated with an almost negligible morbidity up to 4 years of life. Colinfant Newborn, a lyophilized strain of Esherichia coli (E. coli), and a normal component of intestinal flora, readily colonizes the intestinal tract. It's long term presence significantly stimulates the production of specific and non-specific intestinal antibodies. and optimalizes immune development through tolerance. In our study Colinfant Newborn reduced the incidence of infections later in life by safely and effectively normalizing immunoglobulin levels in the majority of treated patients. CONCLUSION: Our study strongly suggests as positive effect of physiological Escherichia coli on the microbiome of newborn children as evidenced by a significantly reduced incidence of allergy and morbidity when applied early in life. These benefits appear to be strongly strain specific.

Department of Clinical Chemistry and Hematology Mulac Hospital Pilsen Czech Republic

Department of Health Accounting and Statistics University Hospital Pilsen Pilsen Czech Republic

Department of Pediatrics Charles University Faculty of Medicine Faculty Hospital Pilsen Czech Republic

Mulac Hospital Newborn Department Pilsen Czech Republic

Zobrazit více v PubMed

Salvatore S, Keymolen K, Hauser B, Vandenplas Y. Intervention during pregnancy and allergic disease in the offspring. Pediatr Allerg Immunol. 2005;16:558–566. doi: 10.1111/j.1399-3038.2005.00315.x. PubMed DOI

Wassenaar TM, Panigrahi P. Is a foetus developing in a sterile environment? Lett Appl Microbiol. 2014;59(6):572–579. doi: 10.1111/lam.12334. PubMed DOI

Glaser J, Johnstone DE. Prophylaxis of allergic disease in the newborn. J Am Med Assoc. 1953;153:620–622. doi: 10.1001/jama.1953.02940240012003. PubMed DOI

Romagnini E, et al. Increased numbers of Th2-like CD4+ T cells in target organs and in the allergen-specific repertoire of allergic patients. Possible role of IL-4 produced by non-T cells. Int Arch Allergy Appl Immunol. 1991;94(1–4):133–136. doi: 10.1159/000235344. PubMed DOI

Kaufman HS. Allergy in the newborn: skin tests reactions confirmed by the Prausnitz-Künster test at birth. Clin Allergy. 1971;1(4):363–367. doi: 10.1111/j.1365-2222.1971.tb00787.x. PubMed DOI

Hrdý J, et al. Exprese cytokinů v buňkách pupečníkové krve a cytokiny v prenatálním a časném postnatálním období dětí zdravých a alergických matek. (Cytokine expression values in cord blood cells and cytokines in the prenatal and early postnatal period of kids with healthy and allergic mothers) Vox Pediatriae. 2007;10(8):32.

Bousquet J, Ménardo JL, Viala JL, Michel FB. Predictive value of cord serum IgE determination in the development of “early on-set” atopy. Ann alergy. 1983;51:291–295. PubMed

Isolauri E, Kalliomäki M, Laitinen K, Salminen S. Modulation of the maturing gut barrier and microbiota: a novel target in allergic disease. Cur Pharm Des. 2008;14(14):1368–1375. doi: 10.2174/138161208784480207. PubMed DOI

Mueller NT, Bakacs E, Combellick J, Grigoryan Z, Dominguez-Bello MG. The infant microbiome development: mom matters. Trends Mol Med. 2015;21(2):109–17. PubMed PMC

Miller DL, Hirvonen T, Gitlin D. Synthesis of IgE by the human conceptus. J Allergy Clin Immunol. 1973;52(3):182–188. doi: 10.1016/0091-6749(73)90035-3. PubMed DOI

Liska J, Holeček V, Siala K, Sobotová Š, Trefil L, Racek J, Sýkora J, Šefrna F. Umbilical IgE and Advanced Glycation Products in Association with Allergies in Childhood. Immun, Endoc. §Metab. Agents in Med. Chem. 2016;16:142–145. doi: 10.2174/1871522216666161018145434. DOI

Kjellman NI, Johannson SG. IgE and atopic allergy in newborns and infants with a family history of atopic disease. Acta Paediatr Scand. 1976;65(5):601–607. doi: 10.1111/j.1651-2227.1976.tb04939.x. PubMed DOI

Petrů P, Špičák V. a kol. Vývoj alergie v průběhu života (Development of allergy during their lifetime). Galén: Alergologie; 2004. p. 149–51.

Zavázal V. Atopie a imunita (Atopy and immunity). UK Praha; 1983. p. 21–58.

Edenharter G, Bergmann RL, Bergmann KE, Wahn V, Forster J, Zepp F, Wahn U. Cord blood –IgE as risk factor and predictor for atopic diseases. Clin Exp Allergy. 1998;28(6):671–678. doi: 10.1046/j.1365-2222.1998.00241.x. PubMed DOI

Lilja G, Johansson SG, Kusoffsky E, Oman H. IgE levels in cord blood and at 4-5 days of age: relation to clinical symtpoms of atopic disease up to 18 months of age. Allergy. 1990;45(6):436–444. doi: 10.1111/j.1398-9995.1990.tb01094.x. PubMed DOI

Bazaral M, Orgel HA, Hamburger RN. IgE levels in normal infants and mothers and an inheritance hypothesis. J Immunol. 1971;107(3):794–801. https://www.researchgate.net/publication/19056135_IgE_Levels_in_Normal_Infants_and_Mothers_and_an_Inheritance_Hypothesis. PubMed

Rutten N, Van der Gugten A, Uiterwaal C, Vlieger A, Rijkers G, Van der Ent K. Maternal use of probiotics during pregnancy and effects on their offspring’s health in an unselected population. Eur J Pediatr. 2016;175(2):229–235. doi: 10.1007/s00431-015-2618-1. PubMed DOI PMC

Shah PS, et al. The relationship between cord blood immunoglobulin E levels and allergy-related outcomes in young adults. Ann Allergy Asthma Immunol. 2011;106(3):245–251. doi: 10.1016/j.anai.2010.12.006. PubMed DOI PMC

Saavedra JM, et al. Use of probiotics in pediatrics: rationale, mechanisms of action and practical aspects. Nutrition in Clinical Practice. 2007;22(3):351–365. doi: 10.1177/0115426507022003351. PubMed DOI

Liška J, Siala K, Holeček V, Sobotová Š, Kepková M, Šefrna F. Effect of Early Treatment of Newborns by Peroral Colonization Using Non-pathogenic E. coli on the Development of Their Immuno-allergic System. Clin Anti-Inflamm Anti-Allergy Drugs. 2014;1:111–21. https://benthamscience.com/journals/clinical-anti-inflammatory-and-anti-allergy-drugs/volume/1/issue/2/.

Fukushima Y, Kawata I, Hara H, Terada A, Mitsuoka T. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol. 1998;42:39–44. doi: 10.1016/S0168-1605(98)00056-7. PubMed DOI

Strimas J, et al. Significance of IgE level in amniotic fluid and cord blood for the prediction of allergy. Ann Allergy. 1988;61(2):133–136. PubMed

Matsumura T, et al. Congenital sensitization to food in humans. Alergia. 1970;17(4):163–171. PubMed

Blumenthal MN, et al. Preventive allergy: genetics of IgE–mediated diseases. J Allergy ClinImmunol. 1986;78:962–968. doi: 10.1016/0091-6749(86)90286-1. PubMed DOI

Businco L, et al. Predictive value of cord blood IgE levels in “at-risk” newborn babies and influence of type of feeding. Clin Allergy. 1983;13(6):503–508. doi: 10.1111/j.1365-2222.1983.tb02631.x. PubMed DOI

Novák J, Novotná B. Allergy and asthma. GRADA; 2012.

Mečnikov E. The prolongation of life; optimistic studies. London: GP Putnam’s Sons; 1908.

Neaville VA, et al. Developmental cytokine response profiles and the clinical and immunological expression of atopy during the first year of life. J. Allergy Clin Immunol. 2003;112:740–746. doi: 10.1016/S0091-6749(03)01868-2. PubMed DOI

Abrahamsson TR, et al. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Alerg Clin Immunol. 2007;119(5):1174–1180. doi: 10.1016/j.jaci.2007.01.007. PubMed DOI

Pepys J. Immunopathology of allergic lung disease. Clin Allergy. 1973;3:1. PubMed

Hamburger RN, Lenois M, Groshong TE, Miller R, Orgel HA. Development of IgE and allergy during the first year of life: preliminary data. J Allergy Clin Immunol. 1974;539:4A. PubMed

Björkstén B. Effect of intestinal microflora and the environment on the development of asthma of allergy. Springer Semin Immunopathol. 2004;25(3–4):257–270. doi: 10.1007/s00281-003-0142-2. PubMed DOI

Kukkonen K, et al. Probiotics and prebiotics significantly prevent eczema and atopic eczema in infants. J Allergy Clin Immunol. 2007;119(1):192–198. doi: 10.1016/j.jaci.2006.09.009. PubMed DOI

Valsecchi A, et al. Probiotics demonstrate immunomodulatory effects in atopic pediatric patients by increasing the Th1 immune response which counterbalances the dominant Th2 immune response. Pediatr Med Chir. 2008;30(4):197–203. PubMed

Viljanen M, et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy. 2005;60(4):494–500. doi: 10.1111/j.1398-9995.2004.00514.x. PubMed DOI

Vliagoftis H. Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Alergy Asthma Immunol. 2008;101(6):570–579. doi: 10.1016/S1081-1206(10)60219-0. PubMed DOI

Kalliomäki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: a randomised placebo–controlled trial. Lancet. 2001;357:1076–1079. doi: 10.1016/S0140-6736(00)04259-8. PubMed DOI

Kalliomäki M, Salminen S, Poussa T, et al. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet. 2003;361:1869–1871. doi: 10.1016/S0140-6736(03)13490-3. PubMed DOI

Brouwer M, et al. No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy. 2006;36(7):899–906. doi: 10.1111/j.1365-2222.2006.02513.x. PubMed DOI

Thomas DW, Greer FR. Probiotics and prebiotics in pediatrics. Pediatrics. 2010;126:1217–1231. doi: 10.1542/peds.2010-2548. PubMed DOI

Vouloumanou EK, et al. Probiotics for the prevention of respiratory tract infections: a systematic review. Intl J Antim. 2009;Agents 34(3):197. PubMed

Sochorová, V. 2003. „Podávání a účinky aplikace Colinfantu u nedonošených dětí (Administration and application effects of Colinfant in preterm infants).“ Vox.Ped. 9, 7, 3, 26–27.

Deshpande G, et al. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics. 2010;125(5):921–930. doi: 10.1542/peds.2009-1301. PubMed DOI

Katz Y, et al. Early exposure to cow’s milk protein is protective against IgE–mediated cow’s milk protein allergy. J Allergy Clin Immunol. 2010;126(1):77–82. doi: 10.1016/j.jaci.2010.04.020. PubMed DOI

Thon V. Intestinální mikroflóra v raném dětství – úloha při rozvoji infekčních a alergických chorob (Intestinal microflora in early infancy and its role in the course of infectious and allergic diseases) Pediatrie pro praxi. 2011;12(4):252–256.

Braegger C, Chmielewska A, et al. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN comittee on nutrition. J Pediatr Gastroenterol Nutr. 2011;52(2):238–250. doi: 10.1097/MPG.0b013e3181fb9e80. PubMed DOI

Henker J, et al. The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and todlers. Eur J Pediatr. 2007;166(4):311–318. doi: 10.1007/s00431-007-0419-x. PubMed DOI PMC

Kuitunen M, et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol. 2009;123(2):335–341. doi: 10.1016/j.jaci.2008.11.019. PubMed DOI

Lilly DM, Stillwell RH. Probiotics: growth-promoting factors produced by microorganisms. Science. 1965;147:747–748. doi: 10.1126/science.147.3659.747. PubMed DOI

Lodinová-Žádníková R, Cukrowská B. Vliv perorálního osídlení nepatogenním kmenem E.coli po narození na složení střevní flóry, imunitní odpověď a výskyt nozokomiálních infekcí u donošených a nedonošených dětí. Sledování jeho dlouhodobého působení. (Effect of peroral settlement nonpathogenic E. coli after birth on the composition of the intestinal flora, immune response and the incidence of nosocomial infections of infants carried to term and preterm infants) Československá Pediat. 1999;54(6):268–273.

Penna FJ, Péret LA, Vieira LQ, Nicoli JR. Probiotics and mucosal barrier in children. Curr Opin Clin Nutr Metab Care. 2008;11(5):640–644. doi: 10.1097/MCO.0b013e32830a70ab. PubMed DOI